1. In this secondary analysis of the PARADIGM-HF trial, amongst patients receiving mineralocorticoid receptor antagonists, rates of severe hyperkalemia (>6.0 ...
1. Based on a randomized, controlled trial, acute ingestion of caffeine was not pro-arrhythmogenic in chronic systolic heart failure patients ...
1. Patients treated with sacubitril-valsartan experienced reduction in cardiovascular morbidity and mortality. 2. Cost effectiveness of sacubitril-valsartan was sensitive to ...
1. This double-blinded, randomized controlled study found that liraglutide, a GLP-1 agonist, did no better than placebo in influencing post-hospitalization ...
![Adverse pregnancy outcomes associated with thrombophilias [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2015/07/Classics-2-Minute-Medicine-e1436017941513-350x250.png)
1. In patients with end-stage heart failure on optimal medical therapy, treatment with a left ventricular assist device (LVAD) significantly ...
1. In patients with acute myocardial infarction and heart failure/evidence of left ventricular dysfunction, patients treated with valsartan and captopril ...
Longitudinal assessment of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia treated on a contemporary chemotherapy protocol Acute lymphoblastic ...
1. Among patients receiving inpatient treatment for decompensated heart failure, an outpatient intervention consisting of pre-discharge education, telephone coaching, and ...
1. In patients with heart failure, reduced left ventricular ejection fraction, and prolonged QRS>130 ms, treatment with cardiac resynchronization therapy ...
1. Angiotensin-converting-enzyme (ACE) inhibitors had been shown to significantly reduce mortality in patients with heart failure, and it was hypothesized ...
